Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 2 | 2016 | 39 | 1.030 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 88 | 0.690 |
Why?
|
| Immunotherapy | 2 | 2021 | 212 | 0.680 |
Why?
|
| Interleukin-10 | 2 | 2014 | 144 | 0.510 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 595 | 0.450 |
Why?
|
| Colitis | 1 | 2014 | 156 | 0.430 |
Why?
|
| Interferon Type I | 1 | 2011 | 32 | 0.410 |
Why?
|
| Th17 Cells | 1 | 2011 | 116 | 0.380 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 186 | 0.370 |
Why?
|
| Melanoma, Experimental | 2 | 2021 | 95 | 0.360 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.300 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 1533 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 756 | 0.280 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 80 | 0.200 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 46 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 79 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2790 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2021 | 201 | 0.180 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 22 | 0.180 |
Why?
|
| Mice | 4 | 2019 | 8472 | 0.180 |
Why?
|
| PPAR gamma | 1 | 2019 | 95 | 0.170 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 200 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2550 | 0.160 |
Why?
|
| Sphingosine | 1 | 2019 | 315 | 0.150 |
Why?
|
| NLR Proteins | 1 | 2016 | 3 | 0.150 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2016 | 18 | 0.150 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 21 | 0.150 |
Why?
|
| Caspase 1 | 1 | 2016 | 22 | 0.150 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 22 | 0.150 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 138 | 0.140 |
Why?
|
| Inflammation | 2 | 2014 | 1030 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1849 | 0.140 |
Why?
|
| Animals | 5 | 2021 | 20877 | 0.140 |
Why?
|
| Macrophages | 1 | 2016 | 647 | 0.110 |
Why?
|
| Interferon-beta | 1 | 2011 | 17 | 0.100 |
Why?
|
| Interleukins | 1 | 2011 | 79 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2011 | 107 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2019 | 2688 | 0.100 |
Why?
|
| Alleles | 1 | 2011 | 386 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2011 | 489 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 133 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1172 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2673 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1293 | 0.070 |
Why?
|
| Cross-Priming | 1 | 2021 | 10 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 76 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 118 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 397 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 54 | 0.040 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2019 | 63 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1032 | 0.040 |
Why?
|
| Humans | 2 | 2016 | 68525 | 0.040 |
Why?
|
| Female | 2 | 2019 | 38015 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1034 | 0.040 |
Why?
|
| Male | 1 | 2019 | 37281 | 0.010 |
Why?
|